Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
104 studies found for:    "DMD-associated dilated cardiomyopathy" OR "Cardiomyopathy, Dilated"
Show Display Options
Download search resultsDownload the search results for:
"DMD-associated dilated cardiomyopathy" OR "Cardiomyopathy, Dilated" (104 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Suspended Autologous Stem Cells in Pediatric Patients With Dilated Cardiomyopathy
Condition: Cardiomyopathy, Dilated
Intervention: Procedure: Intracoronary autologous stem cell infusion
2 Completed Nesiritide - Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Drug: Nesiritide;   Drug: 5% Dextrose
3 Unknown  Cell Therapy In Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Procedure: Stem cell
4 Completed Use of Ixmyelocel-T (Formerly Cardiac Repair Cell [CRC] Treatment) in Patients With Heart Failure Due to Dilated Cardiomyopathy (IMPACT-DCM)
Condition: Dilated Cardiomyopathy
Intervention: Biological: Cardiac Repair Cells (CRCs)
5 Completed Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Biological: Cardiac Repair Cells (CRCs)
6 Terminated Cell Therapy in Dilated Cardiomyopathy: Observational Study
Condition: Cardiomyopathy, Dilated
Intervention: Other: Cell therapy
7 Not yet recruiting Pathophysiology of Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention:
8 Withdrawn Intravenous Allopurinol to Improve Heart Function in Individuals With Dilated Cardiomyopathy
Conditions: Cardiovascular Diseases;   Cardiomyopathy, Dilated;   Heart Diseases;   Heart Failure, Congestive
Interventions: Drug: Allopurinol;   Drug: Dobutamine
9 Completed Supramaximal Titrated Inhibition of RAAS in Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Drug: Benazepril;   Drug: Valsartan;   Drug: Metoprolol
10 Terminated
Has Results
Immunoadsorption Therapy for Patients With Non-Ischemic Dilated Cardiomyopathy (DCM)
Condition: Cardiomyopathy, Dilated
Intervention: Device: Mysorba
11 Recruiting Safety and Efficacy Study of Intramyocardial Stem Cell Therapy in Patients With Dilated Cardiomyopathy
Conditions: Dilated Cardiomyopathy;   Chronic Heart Failure
Interventions: Procedure: Intramyocardial injection;   Procedure: Intracoronary injection
12 Terminated Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Drug: Rosiglitazone therapy
13 Recruiting Multicenter Study of Immunoadsorption in Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Device: protein A immunoadsorption;   Device: pseudo-immunoadsorption
14 Unknown  Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Biological: CD34+ autologous stem cell transplantation;   Drug: Bone Marrow Stimulation
15 Completed Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Drug: granulocyte colony stimulating factor (GCSF);   Procedure: bone marrow mononuclear cells
16 Recruiting PREclinical Mutation CARriers From Families With DIlated Cardiomyopathy and ACE Inhibitors
Condition: Dilated Cardiomyopathy
Interventions: Drug: perindopril;   Drug: placebo
17 Completed Intracoronary Infusion of Autologous Bone Marrow Cells for Treatment of Idiopathic Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Procedure: Intracoronary infusion of autologous bone marrow cells
18 Completed
Has Results
Coenzyme Q10 Supplementation in Children With Idiopathic Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Drug: Coenzyme Q10;   Drug: Placebo
19 Unknown  Intramuscular Injection of Mesenchymal Stem Cell for Treatment of Children With Idiopathic Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Biological: umbilical cord mesenchymal stem cells
20 Recruiting PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis in Dilated CardioMyopathy (The POSEIDON-DCM Study)
Condition: Non-ischemic Dilated Cardiomyopathy
Interventions: Procedure: Transendocardial injection;   Biological: Autologous hMSCs;   Biological: Allogeneic hMSCs

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years